Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Berger

Showing results (601-610 of 774) with videos related to

Pageof 78
Sort By:
Journal of the American College of Cardiology|September 1, 1995
Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. The GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary ArteriesD R Holmes, E R Bates, N S Kleiman, et al.
Journal of Thrombosis and Haemostasis : JTH|August 21, 2009
Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysisS G Chu, R C Becker, P B Berger, et al.
International Immunology|February 9, 2010
GITR engagement preferentially enhances proliferation of functionally competent CD4+CD25+FoxP3+ regulatory T cellsGongxian Liao, Sushrusha Nayak, Jose R Regueiro, et al.
Chest|July 24, 2008
The primary and secondary prevention of coronary artery disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)Richard C Becker, Thomas W Meade, Peter B Berger, et al.
Circulation|August 31, 2011
Platelet reactivity and cardiovascular outcomes after percutaneous coronary intervention: a time-dependent analysis of the Gauging Responsiveness with a VerifyNow P2Y12 assay: Impact on Thrombosis and Safety (GRAVITAS) trialMatthew J Price, Dominick J Angiolillo, Paul S Teirstein, et al.
Minerva Stomatologica|July 6, 2013
Influence of different photo-activation distances on cytotoxicity of a dental adhesive model resinR V De Carvalho, M R Fernández, R C Poli-Frederico, et al.
American Journal of Obstetrics and Gynecology|December 28, 2014
Use of other treatments before hysterectomy for benign conditions in a statewide hospital collaborativeLauren E Corona, Carolyn W Swenson, Kyle H Sheetz, et al.
Clinical Cardiology|May 20, 2008
Assessing the current role of platelet function testingEugene Braunwald, Dominick Angiolillo, Eric Bates, et al.
JACC. Cardiovascular Interventions|September 21, 2010
Frequency of major noncardiac surgery and subsequent adverse events in the year after drug-eluting stent placement results from the EVENT (Evaluation of Drug-Eluting Stents and Ischemic Events) RegistryPeter B Berger, Neal S Kleiman, Michael J Pencina, et al.
Circulation|November 16, 1999
Cardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevationD R Holmes, P B Berger, J S Hochman, et al.
Pageof 78

Showing results (601-610 of 774) with videos related to

Sort By:
Pageof 78
Journal of the American College of Cardiology|September 1, 1995
Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. The GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary ArteriesD R Holmes, E R Bates, N S Kleiman, et al.
Journal of Thrombosis and Haemostasis : JTH|August 21, 2009
Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysisS G Chu, R C Becker, P B Berger, et al.
International Immunology|February 9, 2010
GITR engagement preferentially enhances proliferation of functionally competent CD4+CD25+FoxP3+ regulatory T cellsGongxian Liao, Sushrusha Nayak, Jose R Regueiro, et al.
Chest|July 24, 2008
The primary and secondary prevention of coronary artery disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)Richard C Becker, Thomas W Meade, Peter B Berger, et al.
Circulation|August 31, 2011
Platelet reactivity and cardiovascular outcomes after percutaneous coronary intervention: a time-dependent analysis of the Gauging Responsiveness with a VerifyNow P2Y12 assay: Impact on Thrombosis and Safety (GRAVITAS) trialMatthew J Price, Dominick J Angiolillo, Paul S Teirstein, et al.
Minerva Stomatologica|July 6, 2013
Influence of different photo-activation distances on cytotoxicity of a dental adhesive model resinR V De Carvalho, M R Fernández, R C Poli-Frederico, et al.
American Journal of Obstetrics and Gynecology|December 28, 2014
Use of other treatments before hysterectomy for benign conditions in a statewide hospital collaborativeLauren E Corona, Carolyn W Swenson, Kyle H Sheetz, et al.
Clinical Cardiology|May 20, 2008
Assessing the current role of platelet function testingEugene Braunwald, Dominick Angiolillo, Eric Bates, et al.
JACC. Cardiovascular Interventions|September 21, 2010
Frequency of major noncardiac surgery and subsequent adverse events in the year after drug-eluting stent placement results from the EVENT (Evaluation of Drug-Eluting Stents and Ischemic Events) RegistryPeter B Berger, Neal S Kleiman, Michael J Pencina, et al.
Circulation|November 16, 1999
Cardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevationD R Holmes, P B Berger, J S Hochman, et al.
Pageof 78